Product Description |
Recombinant Human PLA2G7 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Phe22-Asn441. |
Product Background |
Endogenous PLA2G7 transcription levels were found to be significantly lower in vascular related cell lines than in the other cell lines. Luciferase reporter gene assays indicated that gene activity was significantly enhanced by PLA2G7 promoter fragment. LA2G7 transcription was found to be up-regulated with the treatment of DAC. The 17-β-estradiol was found to down-regulate PLA2G7 transcription in all the cell lines. |
Product Category |
Recombinant Protein / Antibody discovery |
Protein |
PLA2G7 |
Synonyms |
LDL-PLA2; PAFAD; PAFAH |
Accession |
|
Species |
Human |
Biotinylated |
no |
Amino Acid Range |
Phe22-Asn441 |
Molecular Weight |
The protein has a predicted MW of 48.9 kDa. Due to glycosylation, the protein migrates to 49-60 kDa based on Bis-Tris PAGE result. |
Product Tag |
C-His |
Expression System |
HEK293 |
Purity |
> 95% as determined by Bis-Tris PAGE |
Endotoxin |
Less than 1EU per ug by the LAL method. |
Form |
Liquid |
Shipping |
Shipped with dry ice. |
Formulation |
Supplied as 0.22um filtered solution in 50mM NaAc, 150mM NaCl, 10% Glycerol (pH 5.0). |
Stability And Storage |
Valid for 12 months from date of receipt when stored at -80°C.； Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
|
|
Human PLA2G7 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. |
Related Products
Have more questions?
Check out our Frequently Asked Questions page for more details about product specifications, ordering, and shipments.
Contact Us
More from Antibody Drug Discovery Proteins
Recently viewed
